Idorsia has become the first drugmaker in the EU to claim approval for a drug for chronic insomnia in the dual orexin receptor antagonist class, ahead of rival drugs from Merck & Co and Eisai.
Depletion of gut microbiota results in disruptions in the brain's core ... Sleeping for 2: Insomnia Therapy Reduces Postpartum Depression, Study Shows Oct. 31, 2024 — CBT for insomnia ...